Stéphanie Frey-Koba

Stéphanie FREY-KOBA is an experienced Clinical Study Manager currently at AIXIAL, overseeing clinical studies for Air Liquide Santé International since July 2015, focusing on therapeutic areas including chronic pain, diabetes, ARDS, and sleep apnoea. Responsibilities include writing and validating essential documents, managing submissions to ethics committees and regulatory authorities, overseeing vendor activities, managing investigational products, and facilitating study budgets while implementing risk management strategies. Prior to this role, Stéphanie spent over a decade at Pierre Fabre Group, initially as a Clinical Activities Coordination Attaché and later as a Clinical Activities Coordinator, where responsibilities encompassed coordinating CRAs across multiple countries, training teams, quality control of regulatory documents, and leading IT tool implementations. Stéphanie holds a Master's degree in Biotechnology & Information Systems.